|5.34||-0.0200||-0.37%||Vol 69.96K||1Y Perf 1 340.09%|
|Oct 2nd, 2023 16:00 DELAYED|
|- -||- -%|
|Target Price||3.00||Analyst Rating||Hold 3.00|
|Potential %||-43.82||Finscreener Ranking||★★ 45.69|
|Insiders Trans % 3/6/12 mo.||100/100/100||Value Ranking||★+ 42.82|
|Insiders Value % 3/6/12 mo.||100/100/100||Growth Ranking||★+ 40.87|
|Insiders Shares Cnt. % 3/6/12 mo.||100/100/100||Income Ranking||★★★★ — -|
|Price Range Ratio 52W %||41.57||Earnings Rating||Strong Buy|
|Market Cap||54.46M||Earnings Date||9th Nov 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|6 Months||1 343.24%|
|1 Year||1 340.09%|
|Mngmt Effectiveness||Value||Industry||S&P 500||US Markets|
ROE (5Y Avg)
ROE last 12 Months
ROA (5Y Avg)
ROA last 12 Months
ROC (5Y Avg)
ROC last 12 Months
Return on invested Capital Q
Return on invested Capital Y
|Earnings History||Estimate||Reported||Surprise %|
|Q01 2023||-0.75||-10.94||-1 358.67|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||9th Nov 2023|
|Estimated EPS Next Report||-0.43|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||36.01K|
|Avg. Monthly Volume||110.41K|
|Avg. Quarterly Volume||78.41K|
Aspira Women's Health Inc. (NYSE: AWH) stock closed at 5.34 per share at the end of the most recent trading day (a -0.37% change compared to the prior day closing price) with a volume of 69.96K shares and market capitalization of 54.46M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 53 people. Aspira Women's Health Inc. CEO is Valerie Palmieri.
The one-year performance of Aspira Women's Health Inc. stock is 1340.09%, while year-to-date (YTD) performance is 1505.53%. AWH stock has a five-year performance of -89.16%. Its 52-week range is between 2.3087 and 9.6, which gives AWH stock a 52-week price range ratio of 41.57%
Aspira Women's Health Inc. currently has a PE ratio of -1.50, a price-to-book (PB) ratio of 4.46, a price-to-sale (PS) ratio of 8.47, a price to cashflow ratio of 18.60, a PEG ratio of -, a ROA of -96.00%, a ROC of -110.41% and a ROE of -141.70%. The company’s profit margin is 5.93%, its EBITDA margin is -454.80%, and its revenue ttm is $6.03 Million , which makes it $0.05 revenue per share.
Of the last four earnings reports from Aspira Women's Health Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.43 for the next earnings report. Aspira Women's Health Inc.’s next earnings report date is 09th Nov 2023.
The consensus rating of Wall Street analysts for Aspira Women's Health Inc. is Hold (3), with a target price of $3, which is -43.82% compared to the current price. The earnings rating for Aspira Women's Health Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Aspira Women's Health Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of 36.00%.
Aspira Women's Health Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 16.42, ATR14 : 0.58, CCI20 : 16.62, Chaikin Money Flow : -0.02, MACD : 0.37, Money Flow Index : 76.26, ROC : -11.88, RSI : 57.25, STOCH (14,3) : 40.19, STOCH RSI : 0.57, UO : 53.67, Williams %R : -59.81), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Aspira Women's Health Inc. in the last 12-months were:
Mon, 11 Sep 2023 12:32 GMT Aspira Womens Health appoints Berry as new Chief Scientific Officer- TipRanks. All rights reserved.
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
This could take some time, please wait.